NCT00142558View on ClinicalTrials.gov

A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 1, 2005

Primary Completion Date

May 1, 2005

Study Completion Date

May 1, 2005

Conditions
Acute Gout
Interventions
DRUG

MK0663; etoricoxib / Duration of Treatment: 5 Days

DRUG

Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00142558 - A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED) | Biotech Hunter | Biotech Hunter